BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34626165)

  • 1. Characterization of immune cell infiltrate in tumor stroma and epithelial compartments in oral squamous cell carcinomas of Sudanese patients.
    Gaafar NM; Osman TA; Ahmed IA; Elsheikh M; Dongre H; Jacobsen MR; Mohamed NG; Fromreide S; Suleiman AM; Johannessen AC; Nginamau ES; Costea DE
    Clin Exp Dent Res; 2022 Feb; 8(1):130-140. PubMed ID: 34626165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial PD-L1 expression at tumor front predicts overall survival in a cohort of oral squamous cell carcinomas from Sudan.
    Gaafar NM; Osman TA; Elsheikh M; Ahmed IA; Dongre H; Fromreide S; Suleiman AM; Johannessen AC; Nginamau ES; Costea DE
    Clin Exp Dent Res; 2022 Dec; 8(6):1467-1477. PubMed ID: 36177667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of immune cell markers in feline oral squamous cell carcinoma.
    Sparger EE; Murphy BG; Kamal FM; Arzi B; Naydan D; Skouritakis CT; Cox DP; Skorupski K
    Vet Immunol Immunopathol; 2018 Aug; 202():52-62. PubMed ID: 30078599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma.
    Boxberg M; Leising L; Steiger K; Jesinghaus M; Alkhamas A; Mielke M; Pfarr N; Götz C; Wolff KD; Weichert W; Kolk A
    J Immunol; 2019 Jan; 202(1):278-291. PubMed ID: 30530592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
    Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
    Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
    Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
    Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating FoxP3+ T cells are associated with poor prognosis in oral squamous cell carcinoma.
    Hayashi T; Yoshikawa K; Suzuki S; Gosho M; Ueda R; Kazaoka Y
    Clin Exp Dent Res; 2022 Feb; 8(1):152-159. PubMed ID: 34319010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
    Ruiz-Ranz M; Lequerica-Fernández P; Rodríguez-Santamarta T; Suárez-Sánchez FJ; López-Pintor RM; García-Pedrero JM; de Vicente JC
    Front Immunol; 2022; 13():941351. PubMed ID: 35958590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Analysis of Foxp3
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    Pathol Oncol Res; 2018 Jul; 24(3):497-505. PubMed ID: 28669079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
    Koike K; Dehari H; Ogi K; Shimizu S; Nishiyama K; Sonoda T; Sasaki T; Sasaya T; Tsuchihashi K; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
    PLoS One; 2020; 15(8):e0237465. PubMed ID: 32785290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
    Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
    Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia.
    Ibrahim SO; Vasstrand EN; Johannessen AC; Idris AM; Magnusson B; Nilsen R; Lillehaug JR
    Int J Cancer; 1999 May; 81(4):527-34. PubMed ID: 10225439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm.
    Yao S; Huang Z; Wei C; Wang Y; Xiao H; Chen S; Huang Z
    BMC Oral Health; 2023 Jun; 23(1):411. PubMed ID: 37344840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
    Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
    Xiao T; Lin F; Zhou J; Tang Z
    Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
    Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
    J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tumor-infiltrating T & B lymphocytes and their association and distribution in oral squamous cell carcinoma tumor microenvironment: An in vitro immunohistochemical study.
    Ladke VS; Kumbhar G; Kheur SM; Chougule H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Aug; 136(2):211-219. PubMed ID: 37258329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.